Published Date : Jul 11, 2016
Albany, NY, July 11, 2016: Strategic initiatives by vendors to discover new products and technological advances in POC procedures will boost the demand for blood coagulation analyzers, predict the authors of a newly added report by MarketResearchReports.biz to its vast database. For instance, The Tokyo Medical and Dental University (TMDU) recently conducted a research to study the abilities of blood coagulation analyzers. The researchers found out that the newly developed analyzers to measure blood coagulability are sensitive enough to detect stroke risks in atrial fibrillation (AF) patients. Such discoveries are inspiring leading manufacturers to introduce new blood coagulation analyzers.
The report, titled ‘Global Blood Coagulation Analyzer Market 2016-2020,’ studies this market and features projections for growth. As per the findings of the report, the global blood coagulation analyzer market is expected to exhibit an 8.58% CAGR from 2016 to 2020. Leading players are concentrating on investing more on research and development activities for discovering new medical devices. With this effort, they are aiming to adopt the changing trends and technological advances to manufacture new medical devices. The analysts predict that even though the global blood coagulation analyzer market is set for a significant growth, it may face the challenge of the high cost of research and development activities.
The research defines blood coagulation analyzers and further highlights key factors favoring the market. Blood coagulation analyzers are used in laboratories to test the coagulation effectiveness of blood. It is used to assess various bleeding disorders including hemophilia, factor V Leiden thrombophilia disorder, Von Willebrand diseases, thrombus, thrombocytopenia, leukemia, and polycythemia. Medicines such as aspirin, heparin, and warfarin carry certain side effects which are to be consistently monitored. For instance, heparin doses have to be monitored to avoid the closing of the coronary artery. Blood coagulation analyzers are used by people who take such anticoagulant medicines to monitor their side effects.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/741882
Blood coagulation analyzers find application in physician offices, emergency rooms, group practices, recovery suites, cancer clinics, surgery centers, operating rooms, ambulatory care centers, ICUs and CCUs, birth centers, and nursing homes. The increasing application of blood coagulation analyzers is expected to boost the global market. Advancements in the technology have motivated manufacturers to introduce portable coagulation solutions. Portable coagulation solutions have become one of the most used medical devices for home healthcare.
For a competitive reports, the global blood coagulation analyzer market is regionally divided into the America, Asia Pacific, Europe, and the Middle East and Africa. Key companies operating in various regions are adopting new trends to manufacture portable POC blood coagulation analyzers. Companies such as Abbott Diagnostics, Danaher, Roche Diagnostics, Siemens Healthcare, Sysmex, Accriva Diagnostics, Alere, A&T Corporation, Analyticon Biotechnologies, Cepheid, Corgenix, Diagnostica Stago, and Helena Point of Care are currently operating in the global blood coagulation analyzer market.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org